Olea Medical and NeuroLogica Corporation Partner to Provide Expanded Neuro CT Capabilities

Share Article

Olea Medical, a provider of advanced MR and CT perfusion imaging post-processing, and NeuroLogica Corporation, the only manufacturer of portable computer tomography solutions, partner to provide access to perfusion analysis capabilities to NeuroLogica’s clients of CereTom® and BodyTom®. As part of the agreement, NeuroLogica will offer 4 modules of Olea Sphere enterprise package: a core CT perfusion package made of Perfusion & Analysis Plug-Ins as well as 2 optional modules (Permeability and Longitudinal Mono-Modal CT).

Olea Medical logo

BodyTom® is the world’s first portable, 32-slice, full body scanner. The combination of internal radiation shielding, dual drive system and a revolutionary battery array allow BodyTom® to be transported throughout a hospital or facility and provide essential CT scans to the most critically ill patients while increasing safety to the patient and staff. With an 85cm gantry and 60cm field, BodyTom® produces high quality DICOM images which are compatible with the top names in surgical navigation and planning systems.
The CereTom® is an 8-slice small bore portable CT scanner that delivers the highest quality Non-Contrast, Angiography, and Contrast Perfusion scans in a variety of patient location. Its combination of rapid scan time, easy to use interface and immediate image viewing make CereTom® an indispensable tool for any clinician needing real time, high quality images.

Olea Sphere™ is an image processing software package intended for picture archive, post-processing and communication. It helps standardize both viewing and analysis capabilities of functional and dynamic imaging datasets acquired with MRI and CT across vendors. It features innovative image viewing and analysis, processing of perfusion weighted image post-processing, permeability computation, as well as diffusion weighted image/tensor image post-processing, fiber tracking post-processing, and longitudinal analysis of multiple time points. It is compliant with the DICOM standard and Windows, Macintosh or Linux operating systems. It runs on any standard off-the-shelf workstation or it can be used through a thin deployment with a server.

”NeuroLogica is pleased to announce this partnership with Olea Medical,” said Dr. Eric Bailey, President and CEO of NeuroLogica. “As perfusion imaging becomes critical in emergency cases, particularly in neuroimaging where time is of essence, global access to an integrated neuro CT solution makes it possible to have immediate access to advanced medical imaging. And this is paramount to enhance patient outcomes.”

“Partnering with NeuroLogica is an important milestone for Olea Medical” said Fayçal Djeridane, President and CEO at Olea Medical. “Our primary goal is to expand accessibility of our advanced neuro applications for patients’ benefit worldwide. This partnership will serve as the foundation for providing a standardized platform for neuro CT studies, which enables more efficient patient care.”

About Olea Medical:
Olea Medical designs and markets innovative medical imaging applications that significantly improve diagnostic processes and treatment evaluation. Olea Medical aims to become the leading provider of safe and accurate medical imaging software. More information at http://www.olea-medical.com.

About NeuroLogica Corporation:
Located in Danvers, Massachusetts, NeuroLogica Corp (http://www.neurologica.com) specializes in the design and manufacture of cutting edge imaging equipment that is easy to use and brings the power of imaging to the patient. NeuroLogica`s BodyTom® CT and CereTom® CT are FDA registered and the quality system is certified to ISO 13485:2003 and ISO 9001:2008 with Canadian Medical Device Amendments. NeuroLogica`s BodyTom® CT and CereTom® CT are CE marked (European Conformity) for distribution in the European Union and European Economic Area. More information at http://www.neurologica.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Anca Mitulescu, PhD
Visit website